Synergy between SIRT1 and SIRT6 helps recognize DNA breaks and potentiates the DNA damage response and repair in humans and mice

  1. Fanbiao Meng
  2. Minxian Qian
  3. Bin Peng
  4. Linyuan Peng
  5. Xiaohui Wang
  6. Kang Zheng
  7. Zuojun Liu
  8. Xiaolong Tang
  9. Shuju Zhang
  10. Shimin Sun
  11. Xinyue Cao
  12. Qiuxiang Pang
  13. Bosheng Zhao
  14. Wenbin Ma
  15. Zhou Songyang
  16. Bo Xu
  17. Wei-Guo Zhu
  18. Xingzhi Xu  Is a corresponding author
  19. Baohua Liu  Is a corresponding author
  1. Shenzhen University Health Science Center, China
  2. Shandong University of Technology, China
  3. Sun Yat-sen University, China
  4. Tianjin Medical University Cancer Institute and Hospital, China

Abstract

The DNA damage response (DDR) is a highly orchestrated process but how double-strand DNA breaks (DSBs) are initially recognized is unclear. Here, we show that polymerized SIRT6 deacetylase recognizes DSBs and potentiates the DDR in human and mouse cells. First, SIRT1 deacetylates SIRT6 at residue K33, which is important for SIRT6 polymerization and mobilization toward DSBs. Then, K33-deacetylated SIRT6 anchors to γH2AX, allowing its retention on and subsequent remodeling of local chromatin. We show that a K33R mutation that mimics hypoacetylated SIRT6 can rescue defective DNA repair as a result of SIRT1 deficiency in cultured cells. These data highlight the synergistic action between SIRTs in the spatiotemporal regulation of the DDR and DNA repair in humans and mice.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Fanbiao Meng

    Guangdong Key Laboratory of Genome Stability and Human Disease Prevention, Shenzhen University Health Science Center, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Minxian Qian

    Guangdong Key Laboratory of Genome Stability and Human Disease Prevention, Shenzhen University Health Science Center, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1763-2325
  3. Bin Peng

    Guangdong Key Laboratory of Genome Stability and Human Disease Prevention, Shenzhen University Health Science Center, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Linyuan Peng

    Guangdong Key Laboratory of Genome Stability and Human Disease Prevention, Shenzhen University Health Science Center, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
  5. Xiaohui Wang

    Guangdong Key Laboratory of Genome Stability and Human Disease Prevention, Shenzhen University Health Science Center, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
  6. Kang Zheng

    Anti-aging & Regenerative Medicine Research Institution, School of Life Sciences, Shandong University of Technology, Zibo, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6347-4241
  7. Zuojun Liu

    Guangdong Key Laboratory of Genome Stability and Human Disease Prevention, Shenzhen University Health Science Center, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Xiaolong Tang

    Guangdong Key Laboratory of Genome Stability and Human Disease Prevention, Shenzhen University Health Science Center, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4744-5846
  9. Shuju Zhang

    Guangdong Key Laboratory of Genome Stability and Human Disease Prevention, Shenzhen University Health Science Center, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
  10. Shimin Sun

    Anti-aging & Regenerative Medicine Research Institution, School of Life Sciences, Shandong University of Technology, Zibo, China
    Competing interests
    The authors declare that no competing interests exist.
  11. Xinyue Cao

    Guangdong Key Laboratory of Genome Stability and Human Disease Prevention, Shenzhen University Health Science Center, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
  12. Qiuxiang Pang

    Anti-aging & Regenerative Medicine Research Institution, School of Life Sciences, Shandong University of Technology, Zibo, China
    Competing interests
    The authors declare that no competing interests exist.
  13. Bosheng Zhao

    Anti-aging & Regenerative Medicine Research Institution, School of Life Sciences, Shandong University of Technology, Zibo, China
    Competing interests
    The authors declare that no competing interests exist.
  14. Wenbin Ma

    Key Laboratory of Gene Engineering of the Ministry of Education and State Key Laboratory for Biocontrol, Sun Yat-sen University, Guangzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  15. Zhou Songyang

    Key Laboratory of Gene Engineering of the Ministry of Education and State Key Laboratory for Biocontrol, Sun Yat-sen University, Guangzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  16. Bo Xu

    Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
    Competing interests
    The authors declare that no competing interests exist.
  17. Wei-Guo Zhu

    Biochemistry and Molecular Biology, Shenzhen University Health Science Center, Shenzhen, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8385-6581
  18. Xingzhi Xu

    Guangdong Key Laboratory of Genome Stability and Human Disease Prevention, Shenzhen University Health Science Center, Shenzhen, China
    For correspondence
    xingzhi.xu@szu.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
  19. Baohua Liu

    Guangdong Key Laboratory of Genome Stability and Human Disease Prevention, Shenzhen University Health Science Center, Shenzhen, China
    For correspondence
    ppliew@szu.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1599-8059

Funding

National Key R&D Program of China (2017YFA0503900)

  • Wei-Guo Zhu
  • Baohua Liu

National Natural Science Foundation of China (91849208,81972602,81702909,81871114,81601215)

  • Minxian Qian
  • Zuojun Liu
  • Xiaolong Tang
  • Xingzhi Xu
  • Baohua Liu

National Natural Science Foundation of Guangdong Province (2015A030308007,2017B030301016)

  • Minxian Qian
  • Wei-Guo Zhu
  • Xingzhi Xu
  • Baohua Liu

Shenzhen Science and Technology Innovation Commission (ZDSYS20190902093401689,KQJSCX20180328093403969,JCYJ20180507182044945)

  • Baohua Liu

Tianjin Municipal Science Foundation for Youths (18JCQNJC79800)

  • Fanbiao Meng

Youth Foundation of Tianjin Medical University Cancer Institute and Hospital (B1714)

  • Fanbiao Meng

National Natural Science Foundation of China (91949124)

  • Minxian Qian

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Meng et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,175
    views
  • 515
    downloads
  • 58
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Fanbiao Meng
  2. Minxian Qian
  3. Bin Peng
  4. Linyuan Peng
  5. Xiaohui Wang
  6. Kang Zheng
  7. Zuojun Liu
  8. Xiaolong Tang
  9. Shuju Zhang
  10. Shimin Sun
  11. Xinyue Cao
  12. Qiuxiang Pang
  13. Bosheng Zhao
  14. Wenbin Ma
  15. Zhou Songyang
  16. Bo Xu
  17. Wei-Guo Zhu
  18. Xingzhi Xu
  19. Baohua Liu
(2020)
Synergy between SIRT1 and SIRT6 helps recognize DNA breaks and potentiates the DNA damage response and repair in humans and mice
eLife 9:e55828.
https://doi.org/10.7554/eLife.55828

Share this article

https://doi.org/10.7554/eLife.55828

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Angel D'Oliviera, Xuhang Dai ... Jeffrey S Mugridge
    Research Article

    The SARS-CoV-2 main protease (Mpro or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. Here, we show that the human tRNA methyltransferase TRMT1 is recognized and cleaved by SARS-CoV-2 Mpro. TRMT1 installs the N2,N2-dimethylguanosine (m2,2G) modification on mammalian tRNAs, which promotes cellular protein synthesis and redox homeostasis. We find that Mpro can cleave endogenous TRMT1 in human cell lysate, resulting in removal of the TRMT1 zinc finger domain. Evolutionary analysis shows the TRMT1 cleavage site is highly conserved in mammals, except in Muroidea, where TRMT1 is likely resistant to cleavage. TRMT1 proteolysis results in reduced tRNA binding and elimination of tRNA methyltransferase activity. We also determined the structure of an Mpro-TRMT1 peptide complex that shows how TRMT1 engages the Mpro active site in an uncommon substrate binding conformation. Finally, enzymology and molecular dynamics simulations indicate that kinetic discrimination occurs during a later step of Mpro-mediated proteolysis following substrate binding. Together, these data provide new insights into substrate recognition by SARS-CoV-2 Mpro that could help guide future antiviral therapeutic development and show how proteolysis of TRMT1 during SARS-CoV-2 infection impairs both TRMT1 tRNA binding and tRNA modification activity to disrupt host translation and potentially impact COVID-19 pathogenesis or phenotypes.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Qian Wang, Jinxin Liu ... Qian Liu
    Research Article

    Paramyxovirus membrane fusion requires an attachment protein for receptor binding and a fusion protein for membrane fusion triggering. Nipah virus (NiV) attachment protein (G) binds to ephrinB2 or -B3 receptors, and fusion protein (F) mediates membrane fusion. NiV-F is a class I fusion protein and is activated by endosomal cleavage. The crystal structure of a soluble GCN4-decorated NiV-F shows a hexamer-of-trimer assembly. Here, we used single-molecule localization microscopy to quantify the NiV-F distribution and organization on cell and virus-like particle membranes at a nanometer precision. We found that NiV-F on biological membranes forms distinctive clusters that are independent of endosomal cleavage or expression levels. The sequestration of NiV-F into dense clusters favors membrane fusion triggering. The nano-distribution and organization of NiV-F are susceptible to mutations at the hexamer-of-trimer interface, and the putative oligomerization motif on the transmembrane domain. We also show that NiV-F nanoclusters are maintained by NiV-F–AP-2 interactions and the clathrin coat assembly. We propose that the organization of NiV-F into nanoclusters facilitates membrane fusion triggering by a mixed population of NiV-F molecules with varied degrees of cleavage and opportunities for interacting with the NiV-G/receptor complex. These observations provide insights into the in situ organization and activation mechanisms of the NiV fusion machinery.